1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites
Image: Colourbox/S. Jarry

When Botox meets fat-freezing champion

February 13, 2017

Botox maker Allergan has said it's acquiring Zeltiq Aesthetics and its technology for freezing away fat without surgery. The venture is believed to represent a huge market opportunity worldwide and a growing business.


Drug giant Allergan said Monday it was buying Zeltiq Aesthetics for $2.5 billion (2.36 billion euros), paying $56.50 for each share of Zeltiq and its CoolSculpting system, which essentially freezes away unwanted fat.

The patented cooling technology permits clients to experience "body contouring" without surgery.

"The venture represents a $4-billion market opportunity worldwide," said Allergan, which is headquartered in Ireland.

In Good Shape - Beauty tends

Delighted investors

California-based Zeltiq Aesthetics applies intense cold to body areas, creating a sensation of numbness and involving no needles. The company insists patients can observe first changes after three weeks.

By adding the best-in-class body contouring to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings, we are creating a world-class aesthetics business, Allergan Chief Executive Brent Saunders said in a statement.

The transaction needs approval by Zeltiq shareholders and is subject to regulatory review. Shares of Zeltiq jumped almost 13 percent in midday trading, while Allergan shares added close to 1 percent.

hg/sri (AP, AFP)


Skip next section DW's Top Story

DW's Top Story

Ukrainian servicemen from the Special Operations Forces (OPFOR) 214 Brigade load their tank with ammunition, at an undisclosed location along the frontline north of Bakhmut, Ukraine on March 16, 2023.

Ukraine updates: Kyiv prepares for counterassault

Skip next section More stories from DW
Go to homepage